Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001104659-25-006734·Myers Michael
Schedule 13D ownership disclosure
QUOIN PHARMACEUTICALS LTD
Ordinary Shares, no par value per share (represented by American Depositary Shares) · CUSIP: 74907L300
Event date: 2025-01-27
- Filing-level shares
- 939,230.00
- Percent of class
- 4.9%
- Michael MyersReported CIK 0001959547
Shares: 939,230.00 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-006734
- Form type
- SCHEDULE 13D/A
- Filer
- Myers Michael
- CIK
- CIK 1959547
- Filed
- Jan 28, 2025
- Reporting period
- Jan 27, 2025
- Description
- Schedule 13D beneficial ownership